Genomewide association analysis of warfarin dose requirements in Middle Eastern and North African populations
Abstract To date, there has been no genomewide association study (GWAS) from the Middle East and North African (MENA) region to identify genetic variants associated with warfarin dose variability using this approach. In this study, we aimed to conduct the first GWAS of warfarin dose requirements in...
Saved in:
Main Authors: | Nihal El Rouby (Author), Mohamed H. Shahin (Author), Loulia Bader (Author), Sherief I. Khalifa (Author), Hazem Elewa (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical versus fixed warfarin dosing and the impact on quality of anticoagulation (The ClinFix trial)
by: Amr M. Fahmi, et al.
Published: (2024) -
Benchmarking Health Systems in Middle Eastern and North African Countries
by: Huihui Wang, et al.
Published: (2017) -
Genomewide association study for onset age in Parkinson disease
by: Halter Cheryl, et al.
Published: (2009) -
Implications of Polymorphisms in the BCKDK and GATA‐4 Gene Regions on Stable Warfarin Dose in African Americans
by: Salma A. Bargal, et al.
Published: (2021) -
Disparities in Health Insurance Among Middle Eastern and North African American Children in the US
by: Florence J. Dallo, et al.
Published: (2024)